EBQ:CORTICUS Trial

Revision as of 01:49, 12 December 2013 by Ostermayer (talk | contribs)
incomplete Journal Club Article
Sprung CL, et al. "Hydrocortisone therapy for patients with septic shock". New England Journal of Medicine. 2008. 358(2):111-24.
PubMed Full text PDF


Clinical Question

Does low-dose hydrocortisone therapy improve survival in patients with septic shock?

Conclusion

Hydrocortisone increase the speed to shock reversal.

Major Points

2012 Guidelines

Design

Inclusion Criteria

Exclusion Criteria

Interventions

Outcome

Primary Outcomes

Secondary Outcomes

Subgroup analysis

Criticisms

Funding

Supported by the European Commission, the European Society of Intensive Care Medicine, the European Critical Care Research Network, the International Sepsis Forum, and the Gorham Foundation. Roche Diagnostics provided the Elecsys cortisol immunoassay.

CME

1 Regarding hydrocortisone therapy for patients with septic shock, which of the following statements is true?

hydrocortisone improved survival in patients with septic shock who did not have a response to corticotropin
hydrocortisone hastened reversal of shock in patients with septic shock who did not have a response to corticotropin
hydrocortisone increased the incidence of superinfection
hydrocortisone hastened the reversal of shock in patients in whom shock was reversed
hydrocortisone improved survival in patients with septic shock only if they had a response to corticotropin

2 When etomidate was used in the Sprung CL study of hydrocortisone therapy for patients with septic shock, it was found that:

a single dose of etomidate inhibited the metabolism of corticosteroids for 24 hours in patients who were critically ill
an association between etomidate and the likelihood of adrenal hyporesponsiveness was found
both of the above
neither of the above

3 Regarding the use of hydrocortisone in septic shock patients, which of the following was found?

mortality was significantly reduced in patients who received steroids
mortality was only reduced in patients who had a positive corticotropin test
mortality was only reduced in patients who had a negative corticotropin test
shock was reversed more quickly in the steroid group, when compared to the placebo group
there were fewer episodes of superinfection in the steroid group


Sources